17 Years of Biotech Outperforming Pharma Coming to an End?
Below I plot a simple chart – the ratio of the PPH pharma ETF vs. the IBB biotech ETF. After multiple failed break-outs over the past nearly two decades, you’ll see the ratio breaking above 17-yr downtrend resistance line (1)…
LONG-TERM RELATIVE RATIO CHARTS – Healthcare Sector
Beginning with this post I began showing the relative ratios of all US equity industries vs. the SPX across their entire history. Posts will be grouped by sector, and each sector post will show all the relative sub-industries within it. I’ve generally tried to only…
Angelic (Part 2)
In March-15 when the stock was at ~$15.50 we highlighted HALO, a bio-tech company, in this post. Our interest in the name was entirely attributable to its very unique and favorable-looking ascending triangle pattern, which had been developing since 2004…....
4 Years of Biotech Relative Outperformance Appears to Have Run its Course
We’ve been bullish on biotech for a long, long time dating back to summer 2012 in posts outlined here and here. Despite many calling for tops in the space for quite some time, I’ve been reticent to do so, outlining…...
261.8%, 423.6% and 35%
261.8% – the Fib expansion level formed off the DJ Biotech Index’s 2000/2002 high and low, respectively, that the index ascended past in late November at ~1,350-1,400. 423.6% – the Fib expansion level formed off the DJ Biotech Index’s 2000/2002…...
Up Nearly 70% in a Year, The DJ Biotech Index is Approaching our 1,400 Target; Now What?
These guys are nearing the end of their cyclical runs. In July of last year we noted the group was working on a break-out. In that post we suggested the group was highly compelling. We went on to update the…...
Up 43% in Eight Months, What Next for Bio-techs?
All the way back on July 16th we began building a strong bullish case for out-performance in bio-techs. The group is up 43% since then. Along with airlines, I would say bio-tech/healthcare was the group we focused the most amount…...
Bio-Techs Approaching Near-Term Support
We’ve been bullish on this group for as long as we can remember going back a full four months to this post. We’ve talked recently about the possibility for the group to remain a sustainable out-performer here. As of late…
Biotechs Should Continue to Out-Perform Materially
On July 16th we noted pharma and biotechs were working on noteworthy, long-term technical break-outs. Regarding those groups, we said the following in that prior post: “The set-up in bio-tech is the most compelling given that the DJ Bio-tech index has already…
Bio-Tech & Pharma Working on Break-Outs
Both bio-techs and pharmaceuticals are working on quality, long-term technical break-outs in the charts below. The set-up in bio-tech is the most compelling given that the DJ Bio-tech index has already cleared all-time highs from 2000. Should it break its next…...